Pulmatrix Inc (PULM) is not a good buy for a beginner, long-term investor at this time. The company's financial performance is significantly deteriorating, with no positive news or trading trends to support a bullish outlook. Technical indicators are mixed, with bearish moving averages and neutral RSI, and there are no strong proprietary trading signals to suggest immediate action. Additionally, the lack of positive catalysts and weak stock trend projections further reduce its attractiveness.
The MACD is positive and expanding (0.0156), indicating a mild bullish signal. However, the RSI (35.945) is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Support and resistance levels suggest limited upside potential with a pivot at 1.27, R1 at 1.362, and S1 at 1.178. The stock trend analysis indicates a 50% chance of declining by -0.66% in the next day, -1.44% in the next week, and -4.96% in the next month.
NULL identified. No recent news, hedge fund activity, insider trading, or congress trading data to suggest positive momentum.
The company's financials for Q4 2025 show a complete revenue drop (-100% YoY), significant net income loss (-53.27% YoY), negative EPS (-0.25, down -53.70% YoY), and gross margin collapse (-100% YoY). Additionally, stock trends suggest a higher probability of short-term declines.
In Q4 2025, Pulmatrix Inc reported a complete revenue drop to 0 (-100% YoY), a net income loss of -$928,000 (-53.27% YoY), and an EPS of -0.25 (-53.70% YoY). Gross margin also dropped to 0 (-100% YoY), reflecting severe financial deterioration.
No recent analyst ratings or price target changes available.
